期刊文献+

伊班膦酸钠联合钙尔奇D治疗老年女性骨质疏松症32例疗效观察 被引量:2

Observations of therapeutic effects of ibandronate combined with calcium in 32 patients with osteoporosis in elderly women
在线阅读 下载PDF
导出
摘要 目的探讨伊班膦酸钠联合钙尔奇D治疗老年女性骨质疏松症的疗效。方法对32例老年女性骨质疏松患者进行自身前后对照研究。患者年龄60~85(平均71±8.3)岁,每日服钙尔奇D0.6g,每隔3个月静脉滴注1次伊班磷酸钠2mg,疗程12个月,对比治疗前后的骨密度变化。结果治疗12个月后,患者腰椎、股骨颈、大转子及ward’s三角骨密度显著增加(均P<0.001),增幅分别达6.6%、2.4%、2.3%及3.5%。结论伊班磷酸钠联合钙尔奇D治疗老年女性骨质疏松症有效且使用方便。 Objective To observe the effect of ibandronate combined with calcium in the treatment of osteoporosis in elderly women. Methods 32 elderly women,aged 60 -85 years old with osteoporosis,took calcium 0. 6g/d and received ibandronate 2 mg every 3 month for 12 months. Bone mineral density(BMD) was measured before and after treatment. Results BMD at lumbar,neck,trochanter sites and Ward's were increased by 6.6% ,2.4% ,2.3% and 3.5%, respectivdy( P 〈 0. 001 ). Conclusions Ibandronate combined with calcium is an effective and Convenient medication for osteoporosis in elderly women.
作者 覃保瑜
出处 《内科》 2008年第5期681-682,共2页 Internal Medicine
关键词 骨质疏松症 伊班膦酸钠 碳酸钙 治疗 Osteoporosis lbandronate Calcium Treatment
  • 相关文献

参考文献2

二级参考文献50

  • 1骨质疏松及骨矿盐疾病诊疗指南(讨论稿)[J].国际内分泌代谢杂志,2006,26(4):291-298. 被引量:48
  • 2Chapurlat RD,Palermo L,Ramsay P,et al.Risk of fracture among women who lose bone density during treatment with alendronate[J].Fracture Intervent Trial.Osteoporos Int,2005,16 (7):842-848.
  • 3Genant HK,Grampps,Gluer CC,et al.Universal standardization for dual X-ray absorptiometry:patient and phantom cross-calibration results[J].JBMR,1994,(9):1503 -1514.
  • 4Sharpe M,Noble S,Spencer CM.Alendronate:an update of its use in osteoporosis[J].Drugs,2001,61 (7):999 -1309
  • 5Adriana BD,Rosemary H,Richard E.Monitoring alendronate therapy for osteoporosis[J].J BMR,1999,14 (4):602-607
  • 6Ho AY,Kung AW.Efficacy and tolerability of alendronate once weekly in Asian postmenopausal osteoporotic women[J].Ann Pharmacother,2005,39 (9):1428-1433.
  • 7Bone HG,Hosking D,Devogelaer JP,et al.Ten years' experience with alendronate for osteoporosis in postmenopausal women[J].N Engl J Med,2004,350 (12):1189-1199.
  • 8Thompson DE,Karpf.Treatment with alendronate prevents fractures in women at highest risk:results from the fracture intevention trial[J].Arch Intern Med,2004,157 (22):2617-2624.
  • 9Donahue JG,Chan KA,Andrade SE,et al Gastric and duodenal safety of daily alendronate[J].Arch Intern Med,2002,162(8):936 -42.
  • 10Stone M.Once-weekly treatment for osteoporosis[J].Hosp Med,2002,63 (4):230-232.

共引文献41

同被引文献33

引证文献2

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部